The NKG2D receptor is expressed on the surface on NK cells, NKT cells, γδ T cells, and CD8+ cells and directly interacts with the NKG2DL ligand, whose expression is elevated on the glioma cell surface [190]. The gene discussed is CD8A; the disease is central nervous system cancer.